UK market sees additional Herceptin biosimilar
Accord Healthcare has announced the launch of a Herceptin biosimilar in the UK. Zercepac is the first monoclonal antibody (mAb) and fourth biosimilar launched by the company in Europe.
Archives for September 25, 2020
Novavax starts UK Phase 3 trial of COVID-19 vaccine
Novavax has initiated its first Phase 3 trial to evaluate the efficacy, safety and immunogenicity of its COVID-19 vaccine candidate.